Skip to main content
. 2014 Aug 25;5:405. doi: 10.3389/fimmu.2014.00405

Figure 2.

Figure 2

Time from transplantation to relapse among patients with AML (n = 47) is shown. Patients whose donors have either KIR2DL2 or KIR2DS2 (n = 19, green line) have lower risk for relapse (log-rank p-value 0.059) than patients whose donors do not have those B haplotype defining KIR genes (n = 28, blue line).